Knowledge Base
Recent Additions
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna.
- 2021 Product Catalog
- Enhancement of Transient Transfection with Serum-Free and Blood-Free Transferrin
- zzTest File_DELETE
- Accelerating Vaccine Development Through Use of Blood-Free Components
- Cell Culture Media & The Emergence of Blood-Free Components
- OptiVERO – Virus Production Using VERO Cells with Microcarriers Without Serum in Chemically Defined Cell Culture Media
- OptiVERO – Virus Production Using VERO Cells in Flasks without Serum in Chemically Defined Cell Culture Media Application Note
- OptiVERO – Guidelines for Use
- rHSA Reconstitution Video Protocol
- 2020 Product Catalog
- OptiPEAK HEK293t – Expansion of Adherent HEK293t Cells in Flasks in Chemically Defined Cell Culture Media Application Note
- OptiPEAK HEK 293t – InVitria/Pall Biotech iCELLis Poster
- OptiPEAK HEK293t – Product Specifications
- OptiPEAK HEK293t – Safety Data Sheet
- Optibumin – Safety Data Sheet
- Lysosure – Safety Data Sheet
- Lysobac – Safety Data Sheet
- Lysobac – Brochure – E.Coli Lysis
- Lysobac – Guidelines for Use
- ITSE+A – Guidelines for Use
- ITSE+A – Specifications
- ITSE AF – Safety Data Sheet
- ITSE AF – Guidelines for Use
- ITSE+A – Reducing Serum-Associated Contaminants from Growth Media in Primary Cell Culture Application Note
- ITSE AF – Brochure
- ITS – Guidelines for Use
- ITS – Specifications
- Exbumin – Stabilizing Virus with Albumin to Improve Yield Application Note
- Exbumin – Safety Data Sheet
- Exbumin – Guidelines for Use
- Optiferrin – Product Brochure
- Optiferrin – Using rTransferrin in the Expansion of Hematopoietic Stem Cells Application Note
- Optiferrin – Guidelines for Use
- Utilization of Recombinant Albumins in the Expansion of Human T Lymphocytes
- Cellastim S – Safety Data Sheet
- Cellastim S – Product Specifications
- Cellastim S – Reconstitution Application Note
- Optimizing Antibody Production in Animal-Free Media with the Supplementation of Recombinant Human Albumin (Cellastim™)
- ITSE Animal-Free Brochure
- Albumin Fatty Acid Profiles for cell culture media – Enabling Albumin Optimization for Cell Culture Media
- Accurate nanoelectrode recording of human pluripotent cell-derived cardiomyocytes for assaying drugs and modeling disease
- InVitria: Solving the Vaccine Supply Challenge
- Adherent HEK293t Cells Cultured in Pall’s iCELLis® Bioreactor with OptiPEAK HEK293t Blood-Free Chemically Defined Media Exhibit Robust and Rapid Population Doubling Times
- Expansion of Adherent HEK293t Cells in Flasks in Chemically Defined Cell Culture Media
- SARS-CoV2 and Influenza: A Double Threat
- High-Performance Production of Viral Vectors for Cell and Gene Therapy Using OptiPEAK HEK293t Complete Media
- Recombinant Virus Platforms are Out in Front in the Race to Develop Vaccines Against SARS-CoV-2 and COVID-19 Disease
- Expansion of Adherent HEK293t Cells in Flasks in Chemically Defined Cell Culture Media
- Stabilizing Virus with Albumin to Improve Yield
- Controlling Impurities in Cell Culture Media
- Recombinant Human Leukemia Inhibitory Factor for the Enhanced Expansion of Neural Stem Cells
- Reconstitution of Cellastim S for Cell-Culture Applications
- BioInnovation on Parade: Philly Stands Proud for BIO 2019!
- Using Recombinant Transferrin in the Expansion of Hematopoietic Stem Cells
- T Regulatory Cells, The Next T Cell Frontier?
- Exploring the Latest Research and Opportunities in T-reg Therapy
- Cellastim S Recombinant Human Serum Albumin in the Generation of Functional Cardiomyocytes from Pluripotent Stem Cells
- ASGCT 2019: Remarkable Milestones and Achievements in Cell and Gene Therapy
- Recombinant Albumin for Stabilization of Live-Attenuated Viral Vaccines
- Virus Production Using VERO Cells with Microcarriers Without Serum in Chemically Defined Cell Culture Media
- Virus Production Using VERO Cells in Flasks without Serum in Chemically Defined Cell Culture Media
- Reducing Serum-Associated Contaminants from Growth Media in Primary Cell Culture
- Expansion of VERO Cells Without Serum in Chemically Defined Cell Culture Media
- Universal Vaccine Against Seasonal Influenza Steps Closer to Reality with the Results of FluGen Phase 2 Clinical Trial
- Expansion of T Cells without Serum in Chemically Defined Media
- ECI Conference 2019: The Latest Innovations and Trends in Cell & Gene Therapy
- Phacilitate 2019 and World Stem Cell Summit
- Join InVitria at ECI 2019
- Join InVitria at Phacilitate 2019
- Cellastim S – Guidelines for Use
- Happy Holidays from the InVitria Team!
- BIO Europe 2018: From Lab Innovations to Commercial Realities
- WEBINAR: The Cell Culture Revolution: Commercializing Therapeutic Cell Systems
- InVitria Expands Operations to Anschutz Medical Campus in the Denver Metro Area
- BIO 2018: The Emergence of Gene & Cell Therapy
- InVitria at the American Association of Immunologists 2018 Conference
- Transferrin: An Iron Transport Protein – Recombinant Human Transferrin in Cell Culture Media
- InVitria’s Top Insights from ISCT 2018 – Montreal
- 3 Takeaways from the World Vaccine Congress 2018